Literature DB >> 11571556

Novel PKD1 deletions and missense variants in a cohort of Hellenic polycystic kidney disease families.

I Bouba1, M Koptides, R Mean, C E Costi, K Demetriou, I Georgiou, A Pierides, K Siamopoulos, C C Deltas.   

Abstract

The autosomal dominant form of polycystic kidney disease is a very frequent genetically heterogeneous inherited condition affecting approximately 1 : 1000 individuals of the Caucasian population. The main symptom is the formation of fluid-filled cysts in the kidneys, which grow progressively in size and number with age, and leading to end-stage renal failure in approximately 50% of patients by age 60. About 85% of cases are caused by mutations in the PKD1 gene on chromosome 16p13.3, which encodes for polycystin-1, a membranous glycoprotein with 4302 amino acids and multiple domains. Mutation detection is still a challenge owing to various sequence characteristics that prevent easy PCR amplification and sequencing. Here we attempted a systematic screening of part of the duplicated region of the gene in a large cohort of 53 Hellenic families with the use of single-strand conformation polymorphism analysis of exons 16-34. Our analysis revealed eight most probably disease causing mutations, five deletions and three single amino acid substitutions, in the REJ domain of the protein. In one family, a 3-bp and an 8-bp deletion in exons 20 and 21 respectively, were co-inherited on the same PKD1 chromosome, causing disease in the mother and three sons. Interestingly we did not find any termination codon defects, so common in the unique part of the PKD1 gene. In the same cohort we identified 11 polymorphic sequence variants, four of which resulted in amino acid variations. This supports the notion that the PKD1 gene may be prone to mutagenesis, justifying the relatively high prevalence of polycystic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11571556     DOI: 10.1038/sj.ejhg.5200696

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  3 in total

1.  Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.

Authors:  Miguel A Garcia-Gonzalez; Jeffrey G Jones; Susan K Allen; Christopher M Palatucci; Sat D Batish; William K Seltzer; Zheng Lan; Erica Allen; Feng Qian; Xose M Lens; York Pei; Gregory G Germino; Terry J Watnick
Journal:  Mol Genet Metab       Date:  2007-06-18       Impact factor: 4.797

2.  Locus-specific genetic differentiation at Rw among warfarin-resistant rat (Rattus norvegicus) populations.

Authors:  Michael H Kohn; Hans-Joachim Pelz; Robert K Wayne
Journal:  Genetics       Date:  2003-07       Impact factor: 4.562

3.  Comprehensive PKD1 and PKD2 Mutation Analysis in Prenatal Autosomal Dominant Polycystic Kidney Disease.

Authors:  Marie-Pierre Audrézet; Christine Corbiere; Said Lebbah; Vincent Morinière; Françoise Broux; Ferielle Louillet; Michel Fischbach; Ariane Zaloszyc; Sylvie Cloarec; Elodie Merieau; Véronique Baudouin; Georges Deschênes; Gwenaelle Roussey; Sandrine Maestri; Chiara Visconti; Olivia Boyer; Carine Abel; Annie Lahoche; Hanitra Randrianaivo; Lucie Bessenay; Djalila Mekahli; Ines Ouertani; Stéphane Decramer; Amélie Ryckenwaert; Emilie Cornec-Le Gall; Rémi Salomon; Claude Ferec; Laurence Heidet
Journal:  J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 14.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.